Osteomalacia Treatment Market: Is the Aging Population the Primary Growth Catalyst for Bone Mineralization Therapies?
Aging-driven osteomalacia prevalence — the 61% vitamin D deficiency rate among US older adults, with even higher rates in institutionalized populations and the global population aged 80+ projected to reach 426 million by 2050 creating the demographic tailwind — generates the most commercially significant volume expansion, with the Osteomalacia Treatment Market reflecting geriatric...
0 Commentaires 0 Parts 4 Vue 0 Aperçu